Heron Therapeutics Inc. (HRTX)

[ARBITRARY & CAPRICIOUS]

I remain deeply cautious on FDA approval of this drug for CINV. I also remain gravely concerned that even at these levels the market is irresponsibly assigning a future value to the shares that doesn't reasonably reflect the commercialization challenges. I believe regardless of my view that this will be much higher prior to the 27th as the games are soon to begin....the fund only has < 10% left to go.